Patents by Inventor Li GUI

Li GUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786522
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: October 17, 2023
    Assignee: Nanjing Noratech Pharmaceuticals Co., LTD
    Inventors: Yunzhe Sun, Qi Peng, Cheng-Gang Lin, Li Gui, Zhihui Liu, Fei Liu
  • Publication number: 20230255960
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Applicant: NANJING NORATECH PHARMACEUTICALS CO., LTD.
    Inventors: Yunzhe SUN, Qi PENG, Cheng-Gang LIN, Li GUI, Zhihui LIU, Fei LIU
  • Patent number: 10913721
    Abstract: The present invention relates to a crystalline form N of aripiprazole, pharmaceutical compositions thereof and the use of crystalline form N in the preparation of a medicament for the treatment of central nervous system diseases, especially schizophrenia.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: February 9, 2021
    Assignee: NANJING NORATECH PHARMACEUTICALS CO., LTD
    Inventors: Yun-Zhe Sun, Wei-Ming Jiang, Xin Zhao, Cheng-Gang Lin, Li Gui, Fei Liu
  • Publication number: 20200071293
    Abstract: The present invention relates to a crystalline form N of aripiprazole, pharmaceutical compositions thereof and the use of crystalline form N in the preparation of a medicament for the treatment of central nervous system diseases, especially schizophrenia.
    Type: Application
    Filed: February 19, 2016
    Publication date: March 5, 2020
    Applicant: Noratech Pharmaceuticals, Inc.
    Inventors: Yun-Zhe SUN, Wei-Ming JIANG, Xin ZHAO, Cheng-Gang LIN, Li GUI, Fei LUI
  • Publication number: 20190077826
    Abstract: The present invention discloses method for preparing deoxycholic acid (DCA) or an ester thereof or a pharmaceutically acceptable salt thereof. Said compounds may be applied to remove a fat deposition.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Applicant: NORATECH PHARMACEUTICALS, INC.
    Inventors: Cheng-Gang LIN, Li GUI, Pan CHEN, Zhi-Xuan WANG, Tong-Wei GUAN, Yuan-Yuan YIN, Yu-Ling LU
  • Publication number: 20190070171
    Abstract: The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
    Type: Application
    Filed: March 16, 2016
    Publication date: March 7, 2019
    Applicant: NORATECH PHARMACEUTICALS, INC.
    Inventors: Yunzhe SUN, Qi PENG, Cheng-Gang LIN, Li GUI, Zhihui LIU, Fei LIU
  • Patent number: 10160782
    Abstract: The present invention discloses method for preparing deoxycholic acid (DCA) or an ester thereof or a pharmaceutically acceptable salt thereof. Said compounds may be applied to remove a fat deposition.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: December 25, 2018
    Assignee: NORATECH PHARMACEUTICALS, INC.
    Inventors: Cheng-Gang Lin, Li Gui, Pan Chen, Zhi-Xuan Wang, Tong-Wei Guan, Yuan-Yuan Yin, Yu-Ling Lu
  • Publication number: 20180111960
    Abstract: The present invention discloses method for preparing deoxycholic acid (DCA) or an ester thereof or a pharmaceutically acceptable salt thereof. Said compounds may be applied to remove a fat deposition.
    Type: Application
    Filed: February 26, 2016
    Publication date: April 26, 2018
    Applicant: NORATECH PHARMACEUTICALS, INC.
    Inventors: Cheng-Gang LIN, Li GUI, Pan CHEN, Zhi-Xuan WANG, Tong-Wei GUAN, Yuan-Yuan YIN, Yu-Ling LU